Clinical Trial Details

Trial ID: L0131
Source ID: NCT02927184
Associated Drug: VK2809
Title: Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease
Acronym: --
Status: Completed
Study Results: No Results Available
Results: --
Conditions: Hyperlipidemia|NAFLD
Interventions: Drug: VK2809|Drug: Placebo
Outcome Measures: Change in LDL-C in patients receiving VK2809 compared to placebo
Sponsor/Collaborators: Viking Therapeutics, Inc.
Gender: All
Age: 18 Years to 75 Years ?? (Adult, Older Adult)
Phases: Phase 2
Enrollment: 59
Study Type: Interventional
Study Designs: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
Start Date: September 28, 2016
Completion Date: March 26, 2019
Results First Posted: --
Last Update Posted: April 26, 2021
Locations: Radiant Research, Inc., Chandler, Arizona, United States|SC Clinical Research, Garden Grove, California, United States|ACTCA, Los Angeles, California, United States|Catalina Research Institute, Montclair, California, United States|North America Research, Inc, Pomona, California, United States|Orange County Research Center, Tustin, California, United States|Research Institute of South Florida, Miami, Florida, United States|Research Institute of South Florida, Miami, Florida, United States|Avant Research Associates, LLC, Crowley, Louisiana, United States|HCI- MetroMedic Walk-in, New Bedford, Massachusetts, United States|HCI- MetroMedic Walk-in, New Bedford, Massachusetts, United States|Flint Clinical Research, PLLC, Flint, Michigan, United States|CHEAR Center, LLC, Bronx, New York, United States|Mid Hudson Medical, Hopewell Junction, New York, United States|Wake Research Associcates, LLC., Raleigh, North Carolina, United States|Avant Research, Beaumont, Texas, United States|Clinical Trials of Texas, INC, San Antonio, Texas, United States|Radiant Research, Inc., San Antonio, Texas, United States|Wasatch Clinical Research, LLC, Salt Lake City, Utah, United States
URL: https://ClinicalTrials.gov/show/NCT02927184

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D513 VK2809 Chemical drug DB15137 THR-β agonist -- Under clinical trials Details